EPO

European Patent EP4678097A3 for Neural Interface Implants

The European Patent Office has published patent EP4678097A3 for Synchron Australia Pty Limited, detailing systems and methods for controlling devices using detected changes in neural-related signals. The patent describes a neural interface implanted within a subject's brain to detect these signals and transmit input commands.

European Patent EP4681769A3 for Bodily Organ Flow Control

The European Patent Office has published patent EP4681769A3 for an apparatus designed to control fluid flow within a bodily organ. The patent, assigned to Implantica Patent Ltd., describes an implantable constriction device combined with electrical stimulation to manage bodily matter flow.

European Patent EP4670679A3 for Mitral Valve Prosthesis

The European Patent Office has published patent EP4670679A3 for a two-stage platform for mitral valve replacement, developed by Majoro Cardiac Innovations, LLC. This patent describes a system for percutaneously deploying a mitral annular ring platform and a valved-stent prosthetic device, aiming to provide a consistent platform for various vendors.

EPO Patent Bulletin - CAR for HVG Disease Treatment

The European Patent Office has published a patent bulletin regarding a CAR for use in treating HVG disease. The patent, filed by Medizinische Hochschule Hannover and Technische Universität Braunschweig, describes a nucleic acid encoding a chimeric antigen receptor with specificity for HLA-A*02 for use in suppressing immune rejection of transplants.

Genmab A/S Bispecific Antibodies Against CD3 and CD20 Patent

The European Patent Office published a patent application (EP4678661A3) for Genmab A/S concerning bispecific antibodies targeting CD3 and CD20. The patent abstract details their use in treating diseases requiring T cell-mediated killing of CD20-expressing cells.

EPO Patent Bulletin - Antibodies Binding to Citrullinated Histone

The European Patent Office has published a patent bulletin regarding antibodies binding to citrullinated histone 2A and/or 4, filed by Citryll B.V. The patent, EP4659807A3, relates to antibodies or binding fragments thereof directed against citrulline-containing epitopes, potentially for therapeutic use in Neutrophil Extracellular Trap (NET)-associated pathologies.

EPO Patent EP4671270A3: Purifying Low-pI Antibody

The European Patent Office has published patent application EP4671270A3 concerning a method for purifying antibodies with a low isoelectric point. The patent describes techniques to suppress aggregation and improve impurity removal during antibody purification processes.

Fused Pyrrole/Pyridine Compound for Myt1 Inhibitor Cancer Treatment

The European Patent Office has published patent application EP4711364A1 for Pharmaengine, Inc., detailing a fused pyrrole or pyridine ring compound for use as a Myt1 inhibitor in cancer treatment. The publication includes the compound's formula, its use in a pharmaceutical composition, and a method for its preparation.

Pyridazinone Compounds as Thyroid Hormone Analogs Synthesis Methods

The European Patent Office has published a patent application detailing new synthesis methods for pyridazinone compounds, which act as thyroid hormone analogs. These methods aim to improve purity, yield, and scalability for large-scale preparation, and also describe morphic forms and a treatment method for thyroid hormone resistance.

Shin-Etsu Chemical Patent for Resist Composition

The European Patent Office has published a patent application by Shin-Etsu Chemical Co., Ltd. for a novel onium salt, a chemically amplified positive resist composition, and a resist pattern forming process. The patent aims to improve resolution and reduce line edge roughness in pattern formation.